Stay updated with breaking news from Reproductive Sciences. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Abdulrahman Sinno, MD, discusses the paradigm shift from a histology-based to molecular-based understanding of endometrial cancer and its impact on treatment outcomes.
Investegate announcements from AIM ImmunoTech Announces Positive Top-Line, Protocol-Planned Interim Report Data from the Study of Ampligen Combined with Pembrolizumab for the Treatment of Recurrent Ovarian Cancer
OCALA, Fla., April 10, 2024 -- AIM ImmunoTech Inc. today announced top-line interim data indicating that combining Ampligen with Keytruda in the treatment of recurrent ovarian cancer may have...
SAN FRANCISCO, CA / ACCESSWIRE / April 3, 2024 / Allara Health released the first study to investigate the impact of Polycystic Ovary Syndrome (PCOS) on workplace productivity, led by Dr. Heather Huddleston, MD, Director of the University of California San Francisco PCOS Clinic. Allara is a first-of-its-kind virtual...
Transgender youth are experiencing the catastrophic effects of anti-trans legislation, stigma, and inaccessibility to gender-affirming care.